Log in or Sign up for Free to view tailored content for your specialty!
Lymphoma News
AI has ‘promising utility’ to give high-quality, empathetic answers to patient questions
AI could have the ability to answer some patient questions on cancer instead of clinicians, reducing clinician burdens and improving access to care, according to study results published in JAMA Oncology.
FDA approves Breyanzi CAR-T for follicular lymphoma
The FDA granted accelerated approval to lisocabtagene maraleucel for treatment of adults with relapsed or refractory follicular lymphoma who received at least two prior lines of systemic therapy.
Log in or Sign up for Free to view tailored content for your specialty!
AACR report: Despite progress, disparities in cancer incidence, mortality persist
The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.
Cancer care can drastically affect employment status, income for working adults
As part of routine screening for financial hardship, clinicians should discuss an individual’s employment, access to paid leave and health insurance coverage when constructing a treatment plan relating to cancer care.
Overruled: Fear of litigation unfounded for physicians recommending active surveillance
Allen S. Ho, MD, did not wait to promote active surveillance when he started practicing medicine a decade ago.
Calquence delays disease progression as first-line treatment for mantle cell lymphoma
The addition of acalabrutinib to standard-of-care chemoimmunotherapy significantly extended PFS compared with standard therapy alone in a randomized study, according to press release the agent’s manufacturer.
‘Substantial’ contributions: More than 20% of patients participate in cancer research
More than 20% of patients with cancer participate in some form of clinical study, and that number is considered a “floor” estimate, according to study results published in Journal of Clinical Oncology.
Guidelines: Optimizing vaccinations a ‘critical component’ of effective cancer care
New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.
Blood tests may predict which patients with lymphoma will have poor outcomes after CAR-T
Two blood biomarkers — pre-lymphodepletion C-reactive protein and ferritin — may help predict which patients with lymphoma are at risk for poor outcomes after chimeric antigen receptor T-cell therapy.
Dupilumab treatment for atopic dermatitis linked to cutaneous T-cell lymphoma development
A new study finds that dupilumab is associated with an increased risk for cutaneous T-cell lymphoma in patients taking the drug for atopic dermatitis.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read